Trial
NCT01093183
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Adenocarcinoma of the Prostate
Intervention
lenalidomide
Why stopped
study sponsors withdrew support for the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13